These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28455161)

  • 1. Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria.
    van der Post RS; van Dieren J; Grelack A; Hoogerbrugge N; van der Kolk LE; Snaebjornsson P; Lansdorp-Vogelaar I; van Krieken JH; Bisseling TM; Cats A
    Gastrointest Endosc; 2018 Feb; 87(2):397-404.e2. PubMed ID: 28455161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status.
    Mi EZ; Mi EZ; di Pietro M; O'Donovan M; Hardwick RH; Richardson S; Ziauddeen H; Fletcher PC; Caldas C; Tischkowitz M; Ragunath K; Fitzgerald RC
    Gastrointest Endosc; 2018 Feb; 87(2):408-418. PubMed ID: 28688938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance.
    Lim YC; di Pietro M; O'Donovan M; Richardson S; Debiram I; Dwerryhouse S; Hardwick RH; Tischkowitz M; Caldas C; Ragunath K; Fitzgerald RC
    Gastrointest Endosc; 2014 Jul; 80(1):78-87. PubMed ID: 24472763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk.
    Barber ME; Save V; Carneiro F; Dwerryhouse S; Lao-Sirieix P; Hardwick RH; Caldas C; Fitzgerald RC
    J Pathol; 2008 Nov; 216(3):286-94. PubMed ID: 18825658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.
    Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM
    Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
    Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
    Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort study.
    Lee CYC; Olivier A; Honing J; Lydon AM; Richardson S; O'Donovan M; Tischkowitz M; Fitzgerald RC; di Pietro M
    Lancet Oncol; 2023 Jan; 24(1):107-116. PubMed ID: 36509094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of pathology in the identification of hereditary diffuse gastric cancer: report of a Portuguese family.
    Oliveira C; Moreira H; Seruca R; de Oliveira MC; Carneiro F
    Virchows Arch; 2005 Feb; 446(2):181-4. PubMed ID: 15735979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
    Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
    Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer.
    Tsugeno Y; Nakano K; Nakajima T; Namikawa K; Takamatsu M; Yamamoto N; Fujisaki J; Nunobe S; Kitagawa M; Takeuchi K; Kawachi H
    Am J Surg Pathol; 2020 Sep; 44(9):1204-1212. PubMed ID: 32520759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening.
    Carneiro F; Huntsman DG; Smyrk TC; Owen DA; Seruca R; Pharoah P; Caldas C; Sobrinho-Simões M
    J Pathol; 2004 Jun; 203(2):681-7. PubMed ID: 15141383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer].
    de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH
    Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromoendoscopy in Combination with Random Biopsies for Patients with Pathogenic CDH1 Mutations Undergoing Endoscopic Surveillance.
    Ruf B; Roggia C; Schroeder C; Mattern S; Fend F; Klag T; Götz M
    J Gastrointest Cancer; 2023 Jun; 54(2):520-527. PubMed ID: 35499650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer.
    Majewski IJ; Kluijt I; Cats A; Scerri TS; de Jong D; Kluin RJ; Hansford S; Hogervorst FB; Bosma AJ; Hofland I; Winter M; Huntsman D; Jonkers J; Bahlo M; Bernards R
    J Pathol; 2013 Mar; 229(4):621-9. PubMed ID: 23208944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer predisposition and germline CTNNA1 variants.
    Lobo S; Benusiglio PR; Coulet F; Boussemart L; Golmard L; Spier I; Hüneburg R; Aretz S; Colas C; Oliveira C
    Eur J Med Genet; 2021 Oct; 64(10):104316. PubMed ID: 34425242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of CTNNA1 germline mutations in asymptomatic carriers.
    Benusiglio PR; Colas C; Guillerm E; Canard A; Delhomelle H; Warcoin M; Bellanger J; Eyries M; Zizi M; Netter J; Soubrier F; Parc Y; Mourregot A; Maran Gonzalez A; Cusin V; Denis JA; Coupier I; Svrcek M; Coulet F
    Gastric Cancer; 2019 Jul; 22(4):899-903. PubMed ID: 30515673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric adenocarcinoma of fundic gland type with signet-ring cell carcinoma component: A case report and review of the literature.
    Kai K; Satake M; Tokunaga O
    World J Gastroenterol; 2018 Jul; 24(26):2915-2920. PubMed ID: 30018486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hereditary diffuse gastric cancer].
    Melo Pezo X; Medrano Samamé H; Torres Rosas E
    Rev Gastroenterol Peru; 2015 Jan; 35(1):73-8. PubMed ID: 25875520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with detection of hereditary diffuse gastric cancer on endoscopy in individuals with germline CDH1 mutations.
    Laszkowska M; Tang L; Vos E; King S; Salo-Mullen E; Magahis PT; Abate M; Catchings A; Zauber AG; Hahn AI; Schattner M; Coit D; Stadler ZK; Strong VE; Markowitz AJ
    Gastrointest Endosc; 2023 Sep; 98(3):326-336.e3. PubMed ID: 37094689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.